Comparative Effects of Cholecalciferol and Calcitriol on Circulating Markers of CKD Mineral Bone Disorder | Zendy

Leila R. Zelnick | Zendy; Ian H. de Boer | Zendy; Bryan Kestenbaum | Zendy; Michel Chonchol | Zendy; Jessica Kendrick | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Comparative Effects of Cholecalciferol and Calcitriol on Circulating Markers of CKD Mineral Bone Disorder

Author(s) -

Leila R. Zelnick,

Ian H. de Boer,

Bryan Kestenbaum,

Michel Chonchol,

Jessica Kendrick

Publication year - 2018

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.00480118

Subject(s) - medicine , calcitriol , cholecalciferol , vitamin d and neurology , endocrinology , paricalcitol , bone mineral , calcium , osteoporosis , parathyroid hormone , secondary hyperparathyroidism

CKD mineral and bone disorder (CKD-MBD) is characterized by several inter-related abnormalities in circulating vitamin D metabolites and related regulatory hormones ([1][1]). Reduced kidney function leads to reduced circulating concentrations of 1,25-dihydroxyvitamin D [1,25(OH)2D], the active

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research